Last reviewed · How we verify

NCT07301463

A Study in Children With Achondroplasia

Recruiting now Last updated 24 December 2025
What this trial tests

trial testing No Interventions in Achondroplasia in 260 participants. Currently enrolling.

Timeline
20 June 2025
Primary endpoint
30 December 2028
30 April 2039

Quick facts

Lead sponsorAbbisko Therapeutics Co, Ltd
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment260
Start date20 June 2025
Primary completion30 December 2028
Estimated completion30 April 2039
Sites8 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Abbisko Therapeutics Co, Ltd — full company profile →

Who can join

Adults 30 Months to 11, any sex, with Achondroplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to collect the anthropometric parameters, clinical characteristics, related medical complications, health-related quality of life and treatments of children with ACH, and complete a natural history observation of ACH for at least 6 months and up to 2 years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No Interventions

Trials testing the same drug.

Other recruiting trials for Achondroplasia

Currently open trials in the same condition.

Other Abbisko Therapeutics Co, Ltd trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07301463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing